Highly water-soluble matrix metalloproteinases inhibitors and their effects in a rat adjuvant-induced arthritis model (Q44022790)

29 November 2017

Highly water-soluble matrix metalloproteinases inhibitors and their effects in a rat adjuvant-induced arthritis model (English)

1 reference

29 November 2017

Tetsunori Fujisawa

1

1 reference

29 November 2017

Katsuhiro Igeta

2

1 reference

29 November 2017

Shinjiro Odake

3

1 reference

29 November 2017

Yasuo Morita

4

1 reference

29 November 2017

Junko Yasuda

5

1 reference

29 November 2017

Tadanori Morikawa

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

29 November 2017

13

1 reference

Bioorganic & Medicinal Chemistry

inferred from page(s)

published in

1 reference

29 November 2017

10

1 reference

29 November 2017

8

1 reference

29 November 2017

2569-2581

1 reference

Matrix metalloproteinases: a review

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Design and therapeutic application of matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Matrix metalloproteinases. Novel targets for directed cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Metalloproteinase inhibitors and the prevention of connective tissue breakdown

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Demonstration of tissue collagenase activity in vivo and its relationship to inflammation severity in human gingiva

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

The therapeutic potential of small molecule TACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Design and synthesis of cyclic inhibitors of matrix metalloproteinases and TNF-alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Preclinical antiarthritic activity of matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Anti-arthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNF alpha processing

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Fluorescein isothiocyanate-labeled casein assay for proteolytic enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900109-8

7 January 2021

10.1016/S0968-0896(02)00109-8

Identifiers

DOI

1 reference

29 November 2017

1 reference